What is the recommended dose of midazolam (benzodiazepine) for sedation?

Midazolam Dosing for Sedation

Procedural Sedation (Non-ICU)

For healthy adults under 60 years undergoing procedures, start with 1-2 mg IV administered over at least 2 minutes, then titrate in 1 mg increments every 2-3 minutes to effect, with total doses rarely exceeding 5-6 mg. 1, 2, 3

Standard Adult Dosing Algorithm

• Initial dose: 1-2 mg IV over 2 minutes for healthy adults <60 years 1, 2, 3
• Wait time: Mandatory 2-3 minutes after each dose before administering additional medication to allow peak effect evaluation 2, 3
• Titration: Add 1 mg increments every 2-3 minutes until desired effect (e.g., slurred speech) 3
• Maximum: Total dose rarely exceeds 5-6 mg 1, 3
• Formulation preference: Use 1 mg/mL formulation or dilute 5 mg/mL to facilitate slower injection 4, 3

High-Risk Populations Require Aggressive Dose Reduction

Elderly patients (≥60 years):

• Initial dose: ≤1 mg IV over 2 minutes (not 1.5 mg) 1, 3
• Titration: No more than 1 mg over 2 minutes per increment 3
• Maximum: Total dose rarely exceeds 3.5 mg 1, 3
• Rationale: Reduced clearance and increased risk of hypoventilation/airway obstruction 1, 3

Patients with concomitant opioid use:

• Reduce midazolam dose by 30% due to synergistic respiratory depression 5, 1, 2
• Healthy adults require approximately 30% less midazolam when opioid premedicated 3
• Elderly/debilitated patients require at least 50% dose reduction with concomitant CNS depressants 3

Hepatic or renal impairment:

• Dose reduction mandatory due to decreased clearance 4, 5, 1, 2
• Midazolam accumulates in skeletal muscle and fat with repeated dosing, prolonging duration of effect 4, 5

ASA Physical Status III or greater:

• Reduce dose by 20% or more 1

Obese patients:

• Dose adjustment required due to reduced clearance 1, 2
• Calculate pediatric doses based on ideal body weight 3

Intramuscular Dosing for Preoperative Sedation

• Standard adult dose: 0.07-0.08 mg/kg IM (approximately 5 mg) administered up to 1 hour before surgery 3
• Elderly patients (60+ years): 2-3 mg (0.02-0.05 mg/kg) IM; 1 mg may suffice for some 3
• Onset: Within 15 minutes, peaking at 30-60 minutes 3

---

Pediatric Dosing (Non-Neonatal)

Pediatric dosing is age-dependent and calculated on mg/kg basis, with younger children (<6 years) requiring higher doses per kilogram than older children. 3

Intravenous Dosing by Age Group

6 months to 5 years:

• Initial dose: 0.05-0.1 mg/kg IV over 2-3 minutes 3
• Maximum: Up to 0.6 mg/kg may be necessary, but usually does not exceed 6 mg total 3
• Warning: Higher doses associated with prolonged sedation and hypoventilation risk 3

6 to 12 years:

• Initial dose: 0.025-0.05 mg/kg IV over 2-3 minutes 3
• Maximum: Up to 0.4 mg/kg may be needed, but usually does not exceed 10 mg total 3
• Warning: Higher doses associated with prolonged sedation and hypoventilation risk 3

12 to 16 years:

• Dose as adults, but some may require higher than recommended adult doses 3
• Maximum: Usually does not exceed 10 mg total 3

<6 months of age:

• Limited information available; dosing recommendations unclear 3
• Particularly vulnerable to airway obstruction and hypoventilation 3
• Titrate with small increments (0.05-0.1 mg/kg) and monitor carefully 3

Intramuscular Pediatric Dosing

• Effective dose: 0.1-0.15 mg/kg IM 4, 3
• Higher anxiety: Up to 0.5 mg/kg IM may be used 4, 3
• Maximum: Total dose usually does not exceed 10 mg 3
• Onset: Sedation is age and dose dependent; higher doses result in deeper and more prolonged sedation 3

Critical Pediatric Safety Considerations

• Titration is vital: Administer initial dose over 2-3 minutes, then wait additional 2-3 minutes to evaluate effect before repeating 3
• Midazolam takes 3x longer than diazepam to achieve peak EEG effects 3
• Dedicated monitoring: For deeply sedated pediatric patients, a dedicated individual other than the practitioner performing the procedure should monitor throughout 3
• Dose reduction with concomitant medications: Must reduce midazolam dose when premedicated with opioids or other sedatives 3

---

ICU Continuous Infusion: Benzodiazepines Are No Longer Preferred

Non-benzodiazepine sedatives (propofol, dexmedetomidine) should be used as first-line agents for ICU sedation; midazolam is associated with increased delirium, longer mechanical ventilation, increased ICU length of stay, and higher mortality. 5, 1, 2

Evidence Against Benzodiazepines in ICU

• Benzodiazepine use is among the strongest independent risk factors for ICU delirium 5
• Dexmedetomidine versus midazolam showed decreased delirium (54% vs 76.6%, P<0.001) and fewer ventilator days (3.7 vs 5.6 days, P=0.01) 5
• Recent studies show dramatically reduced midazolam use, with median doses of 0.0026-0.00476 mg/kg/hr when used as rescue sedation 5

When Midazolam Must Be Used in ICU

Loading dose:

• 0.01-0.05 mg/kg IV over several minutes for sedation-naïve adult ICU patients 5, 2

Maintenance infusion:

• 0.02-0.1 mg/kg/hr (1-8 mg/hr for most adults), titrated to target sedation level using validated scales (RASS, Ramsay) 5, 1
• Start at lowest effective dose: 0.02 mg/kg/hr, titrate in small increments every 15-30 minutes 5
• Target lightest sedation level compatible with safety (RASS -1 to 0) 5

Special considerations:

• Active metabolites accumulate, particularly in renal impairment 5
• Monitor closely for prolonged sedation from metabolite accumulation in hepatic or renal impairment 5
• Concomitant opioid use requires 30% reduction in midazolam dose 5

---

Critical Safety Measures (All Settings)

Flumazenil 0.25-0.5 mg IV must be immediately available for reversal, administered in 0.1-0.3 mg incremental boluses. 5, 1, 2

Mandatory Monitoring and Equipment

• Continuous oxygen saturation monitoring during and after procedure 2
• Immediate availability of resuscitative drugs and age/size-appropriate equipment for bag/valve/mask ventilation and intubation 3
• Personnel trained in airway management must be present 3
• Use only in hospital or ambulatory care settings that provide continuous monitoring of respiratory and cardiac function 3

Respiratory Depression Warnings

• Apnea risk persists up to 30 minutes after last dose or discontinuation of infusion 5
• Rapid administration significantly increases apneic episodes 5
• Respiratory depression is dose-dependent and results from depression of central ventilatory response to hypoxia and hypercapnea 4, 5
• Risk is greater in elderly patients, those with chronic disease states or decreased pulmonary reserve 3
• Synergistic respiratory depression occurs with opioid co-administration 1, 2

Neonatal-Specific Warning

• Never administer by rapid injection in neonates 3
• Severe hypotension and seizures reported following rapid IV administration, particularly with concomitant fentanyl 3

---

End-of-Life Care Context

For withdrawal of life-sustaining measures in benzodiazepine-naïve patients, give an initial bolus of 2 mg IV over 5 minutes, followed by maintenance of 1 mg/hr, titrated to symptom control with no dose ceiling. 5, 2

• Rescue boluses equal to or double the hourly rate, every 5 minutes as needed 5
• This context has no dose ceiling; titrate to symptom control 5, 2